MORE►
cancer treatment
Russell Hayward, CEO of Etira Life, sold coffee chain Ascension in 2020. [Image sources: DI Studio; Christoph Burgstedt/istockphoto; Etira Life]
From Coffee Innovator to Cancer Treatment Pioneer: Aussie Expat’s Bold New Mission in Dallas
by Nicole Ward, DRC Data Journalist | Jun 25, 2024
Russell Hayward, CEO of Etira Life and former CEO and founder of Dallas' Ascension coffee chain, has a history of starting a new company about every six years. He discusses Etira Life's cancer treatment approach, upcoming clinical trials, and how his background as a serial entrepreneur prepared him for his latest mission.
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
[Image: iStock Photo, Panuwat Sikham]
Caris Life Sciences Acquires Pharmatech to Pair Patients with Clinical Trials, Faster
by Payton Potter | May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
by Amy Wolff Sorter |
Jun 27, 2017
The Dallas-based luxury coach company offers a discount for riders headed to M.D. Anderson in Houston.
MORE►
